B.A. Tjoa

2.1k total citations
27 papers, 1.7k citations indexed

About

B.A. Tjoa is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, B.A. Tjoa has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in B.A. Tjoa's work include Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (15 papers) and vaccines and immunoinformatics approaches (10 papers). B.A. Tjoa is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (15 papers) and vaccines and immunoinformatics approaches (10 papers). B.A. Tjoa collaborates with scholars based in United States and Italy. B.A. Tjoa's co-authors include Haakon Ragde, Gerald M. Kenny, Alton L. Boynton, G.P. Murphy, S.J. Simmons, M. Rogers, M.J. Troychak, A. Elgamal, Michael L. Salgaller and Gerald P. Murphy and has published in prestigious journals such as The Journal of Immunology, The Journal of Urology and Urology.

In The Last Decade

B.A. Tjoa

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.A. Tjoa United States 17 1.4k 771 748 235 136 27 1.7k
Manuel A. Sepúlveda United States 11 1.6k 1.1× 1.5k 2.0× 486 0.6× 194 0.8× 91 0.7× 16 2.2k
M.J. Troychak United States 10 786 0.5× 423 0.5× 439 0.6× 260 1.1× 69 0.5× 13 1.0k
Jan L. Fisher United States 20 825 0.6× 703 0.9× 412 0.6× 96 0.4× 56 0.4× 37 1.3k
Stefan Störkel Germany 16 539 0.4× 379 0.5× 429 0.6× 255 1.1× 125 0.9× 30 1.2k
Laura Ridolfi Italy 20 877 0.6× 1.2k 1.5× 463 0.6× 309 1.3× 49 0.4× 67 1.6k
Ilenia Pellicciotta United States 14 666 0.5× 742 1.0× 313 0.4× 190 0.8× 44 0.3× 24 1.2k
John Engelhardt United States 11 1.2k 0.8× 1.2k 1.6× 277 0.4× 144 0.6× 59 0.4× 19 1.7k
Amandine Alard United States 10 724 0.5× 851 1.1× 576 0.8× 315 1.3× 37 0.3× 13 1.6k
Sylvie Rusakiewicz France 22 800 0.6× 800 1.0× 322 0.4× 168 0.7× 39 0.3× 44 1.4k
Katharina Bergerhoff United Kingdom 9 1.1k 0.7× 1.2k 1.5× 286 0.4× 92 0.4× 121 0.9× 10 1.5k

Countries citing papers authored by B.A. Tjoa

Since Specialization
Citations

This map shows the geographic impact of B.A. Tjoa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.A. Tjoa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.A. Tjoa more than expected).

Fields of papers citing papers by B.A. Tjoa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.A. Tjoa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.A. Tjoa. The network helps show where B.A. Tjoa may publish in the future.

Co-authorship network of co-authors of B.A. Tjoa

This figure shows the co-authorship network connecting the top 25 collaborators of B.A. Tjoa. A scholar is included among the top collaborators of B.A. Tjoa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.A. Tjoa. B.A. Tjoa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Leisa, B.A. Tjoa, Hestia Mellert, & Gary A. Pestano. (2020). Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donors. Cancer Drug Resistance. 3(3). 563–571. 3 indexed citations
2.
Cavanagh, William, B.A. Tjoa, & Haakon Ragde. (2007). Chemotherapy Followed by Syngeneic Dendritic Cell Injection in the Mouse: Findings and Implications for Human Treatment. Urology. 70(6). S36–S41. 4 indexed citations
3.
Ragde, Haakon, William Cavanagh, & B.A. Tjoa. (2004). DENDRITIC CELL BASED VACCINES: PROGRESS IN IMMUNOTHERAPY STUDIES FOR PROSTATE CANCER. The Journal of Urology. 172(6 Part 2). 2532–2538. 38 indexed citations
4.
5.
Tjoa, B.A. & Gerald P. Murphy. (2000). Development of dendritic-cell based prostate cancer vaccine. Immunology Letters. 74(1). 87–93. 26 indexed citations
6.
7.
Tjoa, B.A. & G. P. Murphy. (2000). Progress in active specific immunotherapy of prostate cancer. Seminars in Surgical Oncology. 18(1). 80–87. 21 indexed citations
8.
Simmons, S.J., B.A. Tjoa, M. Rogers, et al.. (1999). GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial. The Prostate. 39(4). 291–297. 59 indexed citations
9.
Tjoa, B.A., S.J. Simmons, A. Elgamal, et al.. (1999). Follow-up evaluation of a phase II prostate cancer vaccine trial. The Prostate. 40(2). 125–129. 121 indexed citations
10.
11.
Murphy, G.P., B.A. Tjoa, S.J. Simmons, et al.. (1999). Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment. The Prostate. 39(1). 54–59. 153 indexed citations
12.
Tjoa, B.A., S.J. Simmons, Victoria Bowes, et al.. (1998). Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. The Prostate. 36(1). 39–44. 207 indexed citations
13.
Salgaller, Michael L., B.A. Tjoa, Patricia A. Lodge, et al.. (1998). Dendritic Cell-Based Immunotherapy of Prostate Cancer. Critical Reviews in Immunology. 18(1-2). 109–119. 88 indexed citations
14.
Tjoa, B.A., Sheila J. Erickson, Victoria Bowes, et al.. (1997). Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. The Prostate. 32(4). 272–278. 103 indexed citations
15.
Murphy, G.P., B.A. Tjoa, Haakon Ragde, Gerald M. Kenny, & Alton L. Boynton. (1996). Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. The Prostate. 29(6). 371–380. 328 indexed citations
16.
Tjoa, B.A., et al.. (1996). Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity. The Prostate. 28(1). 65–69. 104 indexed citations
17.
Tjoa, B.A., Sheila J. Erickson, Robert J. Barren, et al.. (1995). In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy. The Prostate. 27(2). 63–69. 44 indexed citations
18.
Tjoa, B.A. & David M. Kranz. (1994). Sequence restrictions in T cell receptor β-chains that have specificity for a self-peptide/Ld complex. Molecular Immunology. 31(10). 705–711. 11 indexed citations
19.
Tjoa, B.A. & David M. Kranz. (1994). Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection.. PubMed. 54(1). 204–8. 17 indexed citations
20.
Roth, Matthew E., et al.. (1992). Sequence diversity of T cell receptor α chain transcripts from BALB/c thymus. Molecular Immunology. 29(12). 1447–1455. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel A. Sepúlveda Breakdown of academic impact, for papers by M.J. Troychak Breakdown of academic impact, for papers by Jan L. Fisher Breakdown of academic impact, for papers by Stefan Störkel Breakdown of academic impact, for papers by Laura Ridolfi Breakdown of academic impact, for papers by Ilenia Pellicciotta Breakdown of academic impact, for papers by John Engelhardt Breakdown of academic impact, for papers by Amandine Alard Breakdown of academic impact, for papers by Sylvie Rusakiewicz Breakdown of academic impact, for papers by Katharina Bergerhoff
Rankless by CCL
2026